Detalhe da pesquisa
1.
Associations of stem cell markers CD44, CD24 and ALDH1A1 with mammographic breast density in women with benign breast biopsies.
Br J Cancer;
2024 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38849477
2.
Associations of early-life and adult anthropometric measures with the expression of stem cell markers CD44, CD24, and ALDH1A1 in women with benign breast biopsies.
Cancer Epidemiol Biomarkers Prev;
2024 Apr 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38652503
3.
Associations of reproductive breast cancer risk factors with expression of stem cell markers in benign breast tissue.
Front Oncol;
14: 1354094, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38577336
4.
Associations of stem cell markers in benign breast tissue with subsequent breast cancer risk.
Am J Cancer Res;
13(12): 6280-6289, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38187066
5.
Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis.
Front Med (Lausanne);
9: 1040061, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36590957
6.
Presenilin-based genetic screens in Drosophila melanogaster identify novel notch pathway modifiers.
Genetics;
172(4): 2309-24, 2006 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16415372
7.
Synthetic lethality of retinoblastoma mutant cells in the Drosophila eye by mutation of a novel peptidyl prolyl isomerase gene.
Genetics;
170(1): 161-71, 2005 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15744054